The 100-Day meeting represents a key milestone in the FDA’s PMA review process, providing an opportunity for the company and the FDA review team to discuss preliminary findings of the submission, ...

A European survey found that 27.9% of patients with chronic cough had refractory forms of cough, and 53.6% stopped seeking ...

McGill University researchers have engineered a new hydrogel that shows early promise as a treatment for people with vocal ...

Ironwood Pharmaceuticals Inc said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn ...

Cinclus Pharma Holding AB ( (SE:CINPHA) ) has shared an announcement. Cinclus Pharma has dosed the first patient in its Phase III HEEALING 1 study, which evaluates linaprazan glurate for treating ...

From peppermint tea to cumin seeds, see how five kitchen staples may support digestion, plus cautions for reflux, pregnancy ...

Weight-loss experts explain why combining GLP-1 medications with bariatric surgery may be the most effective approach to ...

Johnson & Johnson (NYSE:JNJ) engages in the research and development, manufacture, and sale of various products in the ...

In patients with T2D, the risks for gastroesophageal reflux disease and related complications are greater with GLP-1 RA ...

Sugary Drinks and Colon Cancer; Reflux Device to Exit Markets; Latino Liver Disease Preclinical research suggested the glucose-fructose blend in sugary drinks may increase the risk for colorectal ...

VADUZ, Liechtenstein, Sept. 25, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop® ...

VADUZ, Liechtenstein, Sept. 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop® ...